The Oncology Institute
Stock Forecast, Prediction & Price Target

The Oncology Institute Financial Estimates

The Oncology Institute Revenue Estimates

The Oncology Institute EBITDA Estimates

The Oncology Institute Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025
Revenue
 
% change YoY
$203.00M
 
N/A
$252.48M
 
24.37%
$324.23M
 
28.42%
Avg: $482.76M
Low: $482.76M
High: $482.76M
avg. 48.89%
Net Income
 
% change YoY
$-10.92M
 
N/A
$1.65M
 
115.16%
$-83.06M
 
-5113.15%
Avg: $-35.26M
Low: $-12.53M
High: $-12.53M
avg. 57.54%
EBITDA
 
% change YoY
$-41.47M
 
N/A
$-67.09M
 
-61.79%
$-70.45M
 
-5.00%
Avg: $-67.13M
Low: $-67.13M
High: $-67.13M
avg. 4.71%
EPS
 
% change YoY
-$0.16
 
N/A
$0.02
 
114.25%
-$0.92
 
-4135.08%
Avg: -$0.17
Low: -$0.17
High: -$0.17
avg. 81.52%
Operating Expenses
 
% change YoY
$86.70M
 
N/A
$124.1M
 
43.12%
$136.59M
 
10.06%
Avg: $159.27M
Low: $159.27M
High: $159.27M
avg. 16.61%

FAQ

What is The Oncology Institute stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 57.54% in 2025-2025.

We have gathered data from 1 analysts. Their low estimate is -12.53M, average is -35.26M and high is -12.53M.

What is The Oncology Institute stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 48.89% in 2025-2025.

We have gathered data from 1 analysts. Their low revenue estimate is $482.76M, average is $482.76M and high is $482.76M.

What is The Oncology Institute stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 81.52% in 2025-2025.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.17, average is -$0.17 and high is $-0.17.